Observations placeholder
Enbrel
Identifier
018949
Type of Spiritual Experience
Background
A description of the experience
Etanercept (trade name Enbrel) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF; a soluble inflammatory cytokine) by acting as a TNF inhibitor. It has U.S. F.D.A. approval to treat rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. TNF-alpha is the "master regulator" of the inflammatory (immune) response in many organ systems.
On Dec, 20, 2016 375,857 people reported to have side effects when taking Enbrel.
Among them, 173 people (0.05%) have Hallucination
Time on Enbrel when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 24.00% | 32.00% | 8.00% | 16.00% | 8.00% | 12.00% | 0.00% |
On Dec, 3, 2015: 175,016 people reported to have side effects when taking Enbrel. Among them, 950 people (0.54%) have Death.
Time on Enbrel when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death12.75%21.81%17.11%13.76%24.16%9.06%1.34%
On Dec, 14, 2015: 175,016 people reported to have side effects when taking Enbrel. Among them, 828 people (0.47%) have Death Of Child.
Time on Enbrel when people have Death of child :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death of child12.65%22.13%16.60%12.25%24.11%10.67%1.58%